PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vitos Klinikum Hochtaunus, Friedrichsdorf, Germany; Heinrich Heine University Duesseldorf, Germany. Electronic address: ansgar.klimke@vitos-hochtaunus.de.\', \'Klinik für Forensische Psychiatrie, Vitos Rheingau Eltville, Germany.\', \'Rheinische Friedrich-Wilhelms-Universität Bonn, University Hospital (UKB), Germany.\', \'Vitos Klinikum Hochtaunus, Friedrichsdorf, Germany; Goethe-Universität Frankfurt am Main, Abt. Allgemeine Psychologie II, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)30707-610.1016/j.mehy.2020.109783
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32402766
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all